Seminars in Nephrology
Volume 25, Issue 6 , Pages 358-362 , November 2005

Predictors of Cardiovascular Death in ESRD

  • Carmine Zoccali

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Professor Carmine Zoccali, CNR-IBIM Istituto di Biomedicina, Epidemiologia Clinica e Fisiopatologia, delle Malattie Renali e dell’Ipertensione, Arteriosa e Unità Operativa di Nefrologia, Dialisi e Trapianto Renale, Ospedali Riuniti, Reggio Calabria, Italy.
    • ,
  • Giovanni Tripepi
    • ,
  • Francesca Mallamaci

References 

  1. Kannel WB , Dawber TR , Kagan A , et al.   Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study . Ann Intern Med . 1961;55:33–50
  2. Kalantar-Zadeh K , Block G , Humphreys MH , et al.   Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients . Kidney Int . 2003;63:793–808
  3. Zimmermann J , Herrlinger S , Pruy A , et al.   Inflammation enhances cardiovascular risk and mortality in hemodialysis patients . Kidney Int . 1999;55:648–658
  4. Yeun JY , Levine RA , Mantadilok V , et al.   C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients . Am J Kidney Dis . 2000;35:469–476
  5. Zoccali C , Benedetto FA , Mallamaci F , et al.   Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients . J Hypertens . 2000;18:1207–1213
  6. Stenvinkel P , Wanner C , Metzger T , et al.   Inflammation and outcome in end-stage renal failure (Does female gender constitute a survival advantage?) . Kidney Int . 2002;62:1791–1798
  7. Mallamaci F , Zoccali C , Tripepi G , et al.   Diagnostic potential of cardiac natriuretic peptides in dialysis patients . Kidney Int . 2001;59:1559–1566
  8. Naganuma T , Sugimura K , Wada S , et al.   The prognostic role of brain natriuretic peptides in hemodialysis patients . Am J Nephrol . 2002;22:437–444
  9. Zoccali C , Bode-Boger S , Mallamaci F , et al.   Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease (A prospective study) . Lancet . 2001;358:2113–2117
  10. Zoccali C , Mallamaci F , Benedetto FA , et al.   Creed investigators cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients . J Am Soc Nephrol . 2001;12:1508–1515
  11. Foley RN , Parfrey PS , Harnett JD , et al.   Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease . J Am Soc Nephrol . 1996;7:728–736
  12. Hosmer DW , Lemeshow S . In: Assessment of model adequacy . New York: Wiley & Sons; 1999;p. 196–240
  13. Ridker PM , Brown NJ , Vaughan DE , et al.   Established and emerging plasma biomarkers in the prediction of first atherothrombotic events . Circulation . 2004;109:IV6–IV19
  14. McDonagh TA , Robb SD , Murdoch DR , et al.   Biochemical detection of left-ventricular systolic dysfunction . Lancet . 1998;351:9–13
  15. Cooke JP . Asymmetrical dimethylarginine (The Uber marker?) . Circulation . 2004;109:1813–1818
  16. Cheung AK , Sarnak MJ , Yan G , et al.   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients . Kidney Int . 2000;58:353–362
  17. Sarnak MJ , Coronado BE , Greene T , et al.   Cardiovascular disease risk factors in chronic renal insufficiency . Clin Nephrol . 2002;57:327–335
  18. Wanner C , Krane V , Ruf G , et al.  Die Deutsche Diabetes Dialyse Studie Investigators   Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis . Kidney Int Suppl . 1999;71:S222–S226
  19. Lauer MS , Blackstone EH , Young JB , et al.   Cause of death in clinical research (Time for a reassessment?) . J Am Coll Cardiol . 1999;34:618–620
  20. Rocco MV , Yan G , Gassman J , et al.  The National Institutes of Health-funded Hemodialysis  Health Care Financing Administration   Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems . Am J Kidney Dis . 2002;39:146–153

PII: S0270-9295(05)00097-5

doi: 10.1016/j.semnephrol.2005.05.002

Seminars in Nephrology
Volume 25, Issue 6 , Pages 358-362 , November 2005

Article Tools

* Image Usage & Resolution